Contraindicated Drug Responses in Dravet Syndrome Brain Organoids Utilizing Micro Electrode Array Assessment Methods
Organoids · 26.10.2023 · 2 (4) · 177-191
DOI: 10.3390/organoids2040014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organoids, online erschienen am 26.10.2023. Verfasst von Remi Yokoi und 4 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, the science research promotion fund.
Abstract (Originalsprache)
Ensuring drug safety for patients with specific neurological disorders is of paramount importance. For instance, certain antiepileptic drugs (AEDs) are contraindicated in Dravet Syndrome (DS), which is characterized by a deficiency in Na+ channel function. Constructing in vitro assessment methods capable of detecting contraindicated drug responses and medication effects on neurons derived from DS patients is highly anticipated for drug safety assessment and therapeutic innovation. This study used micro electrode array (MEA) measurements with low-frequency analysis on human iPSC-derived DS organoids to investigate AED responses. When exposed to the contraindicated drugs carbamazepine and phenytoin, the number of network oscillations increased in DS organoids while maintaining oscillation intensity. Furthermore, carbamazepine administration appeared to enhance activities beyond oscillations which is partially consistent with findings in the DS mouse model. Conversely, treatment with the therapeutic drug sodium valproate resulted in a similar decrease in activity both in healthy and DS organoids. The frequency characteristics of spontaneous firings and AEDs responsiveness in DS organoids demonstrated partial correlation with typical electroencephalography patterns observed in vivo. In conclusion, this study, employing MEA measurements with low-frequency analysis, revealed contraindicated drug responses and disease-specific functional characteristics in DS organoids, effective for DS patient safety assessment, precision medicine, and antiepileptic drug screening.
Förderung
- JSPS KAKENHI
- the science research promotion fund
Zitieren
APA
Yokoi, R., Nagafuku, N., Ishibashi, Y., Matsuda, N., & Suzuki, I. (2023). Contraindicated Drug Responses in Dravet Syndrome Brain Organoids Utilizing Micro Electrode Array Assessment Methods. Organoids, 2(4), 177-191. https://doi.org/10.3390/organoids2040014
Vancouver
Yokoi R, Nagafuku N, Ishibashi Y, Matsuda N, Suzuki I. Contraindicated Drug Responses in Dravet Syndrome Brain Organoids Utilizing Micro Electrode Array Assessment Methods. Organoids. 2023;2(4):177-191. doi:10.3390/organoids2040014
BibTeX
@article{Yokoi2023,
author = {Yokoi, Remi and Nagafuku, Nami and Ishibashi, Yuto and Matsuda, Naoki and Suzuki, Ikuro},
title = {Contraindicated Drug Responses in Dravet Syndrome Brain Organoids Utilizing Micro Electrode Array Assessment Methods},
journal = {Organoids},
year = {2023},
volume = {2},
number = {4},
pages = {177--191},
doi = {10.3390/organoids2040014}
}
EUVIMED